PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR

PREFILLED SYRINGE (ENOXOPARIN) BIOSIMILAR
Product Description

ENOXAPARIN PFS 100MG/ML

Read more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile
Categories
more categories Show less
Specifications
  • Details
    Venus Remedies Ltd has an annual capacity for producing more than 50 lakh units of Enoxaparin, a widely used anticoagulant that prevents blood clots, at its robotic line.

    Read more at:
    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/venus-remedies-gets-marketing-approval-for-anticoagulant-drug-in-saudi-arabia/articleshow/103138194.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
  • Selling Points
    Brand Name; Convenience; Ethical Sourcing; Guarantee/Warranty; International Approvals/Standards; Packaging; Product Features; Product Performance; Prompt Delivery; Quality Service; Reputation; Sustainability; CMO/CDMO Contract Research Organisation (CRO) Generics/Biosimilars Manufacturer Manufacturer/Innovator Pharmaceutical company
  • Model
    20 MG | 80 MG | 40 MG | 60 MG
  • Supplied from
    Germany; India
More specifications Fewer specifications
Sales Markets
Show more Show less

Venus Pharma GmbH

  • DE
  • 2019
    On CPHI since
  • 5
    Certificates
  • 1000 - 4999
    Employees
Company types
CMO/CDMO
Contract Research Organisation (CRO)
Generics/Biosimilars Manufacturer
Manufacturer/Innovator
Pharmaceutical company
Primary activities
Clinical Research
Contract Manufacturer
Contract Research Organisation
Custom Manufacturing/Custom Synthesis
Pharmaceutical Company (generic finished products)
Pharmaceutical Company (innovator finished products)
Regulatory Affairs
View company profile

More Products from Venus Pharma GmbH (4)

  • ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    Product ANTIBIOTIC INJECTABLES (FOR CRITICAL CARE)

    CEFEPIME FOR INJECTION | CEFTRIAXONE | CEFTAZIDIME FOR INJECTION | CEFOPERAZONE + SULBACTAM FOR INJECTION | CEFUROXIME FOR INJECTION | CEFOTAXIME FOR INJECTION | CEFTAZIDIME AVIBACTAM FOR INJECTION | CEFTRIAXONE SULBACTAM FOR INJECTION | ELORES: CEFTRIAXONE, SULBACTAM & EDTA FOR INJECTION | AZTREONAM F...
  • ONCOLOGY LIQUID INJECTABLES

    Product ONCOLOGY LIQUID INJECTABLES

    CARBOPLATIN | CISPLATIN | CYTARABINE LIQUID | DOCETAXEL WITH SOLVENT | DOCETAXEL (CTD) SINGLE VIAL | DOXORUBICIN | EPIRUBICINE | ETOPOSIDE  | IRINOTECAN | LEUCOVORIN CALCIUM | METHOTREXATE | OXALIPLATIN | PLERIXAFOR | PACLITAXEL  | VINCRISTINE | 5-FLOUROURACIL | FULVESTRANT
  • ONCOLOGY LYOPHILIZED INJECTABLES

    Product ONCOLOGY LYOPHILIZED INJECTABLES

    AZACITIDINE | BENDAMUSTINE  | BLEOMYCIN | BORTEZOMIB | CYTARABINE  | DACARBAZINE | EPIRUBICIN  | GEMCITABINE | PEMETREXED | TOPOTECAN | ZOLENDRONIC ACID
  • OTHER INJECTABLES

    Product OTHER INJECTABLES

    REMDESIVIR FOR INJECTION | ACECLOFENAC | CISATRACURIUM BESYLATE | CITICOLINE | DEXMETOMIDINE | L-ORNITHINE L-ASPARTATE | MIDAZOLAM INJ | N-ACETYLCYSTEINE | SUGAMMADEX| PARACETAMOL

Venus Pharma GmbH resources (2)

  • Venus Remedies has secured marketing authorization (MA) for Ceftriaxone 1gm & 2gm in the German market

    News Venus Remedies has secured marketing authorization (MA) for Ceftriaxone 1gm & 2gm in the German market

    Venus Remedies has secured marketing authorization (MA) for Ceftriaxone 1gm & 2gm in the German market. This achievement reinforces Venus Remedies' dedication to delivering high-quality treatments for combating bacterial infections and ensuring patients have access to the latest medical advancements.Click on the link to know more: https://venusremedies.com/blog/chemotherapy-drug
    4 Mar 2024
  • Venus Remedies Secures Coveted UNICEF Approval for Global Impact

    Brochure Venus Remedies Secures Coveted UNICEF Approval for Global Impact

    Venus Remedies Limited, a leading pharmaceutical company with a global footprint, is proud to announce its recent attainment of Good Manufacturing Practices (GMP) approval from the United Nations Children's Fund (UNICEF). This approval signifies a significant milestone for the company, highlighting its unwavering commitment to delivering top-tier pharmaceutical solutions worldwide.